持续非卧床腹膜透析十年经验

Ten years' experience with continuous ambulatory peritoneal dialysis.

作者信息

Rotellar C, Black J, Winchester J F, Rakowski T A, Mosher W F, Mazzoni M J, Amiranzavi M, Garagusi V, Alijani M R, Argy W P

机构信息

Department of Medicine, Georgetown University Medical Center, Washington, DC 20007.

出版信息

Am J Kidney Dis. 1991 Feb;17(2):158-64. doi: 10.1016/s0272-6386(12)81122-x.

DOI:10.1016/s0272-6386(12)81122-x

PMID:1992656

Abstract

Up to January 1989, 171 patients were trained at our center on continuous ambulatory peritoneal dialysis (CAPD), and 17 on continuous cyclic peritoneal dialysis (CCPD). Over 10 years, we have gained 5,068 patient-months experience. Patient survival was 60% and 31% at 5 and 10 years, respectively. In contrast, diabetics had a survival of 32% at 5 years. Major complications included 499 new episodes of peritonitis, 304 exit-site infections, 22 hernias, five bowel perforations, one hydrothorax, and three episodes of sclerosing encapsulating peritonitis. Our technique survival has been 62% and 40% at 5 and 10 years, respectively. We believe that CAPD is a viable dialysis technique for long-term treatment of chronic renal failure and it should be offered as an option to intermittent hemodialysis.

摘要

截至1989年1月，我们中心对171例患者进行了持续性非卧床腹膜透析（CAPD）培训，对17例患者进行了持续性循环腹膜透析（CCPD）培训。在10多年的时间里，我们积累了5068个患者月的经验。患者5年和10年的生存率分别为60%和31%。相比之下，糖尿病患者5年生存率为32%。主要并发症包括499例新发腹膜炎、304例出口处感染、22例疝气、5例肠穿孔、1例胸腔积液和3例硬化性包裹性腹膜炎。我们的技术生存率5年和10年分别为62%和40%。我们认为，CAPD是一种治疗慢性肾衰竭的可行透析技术，应作为间歇性血液透析的一种选择提供给患者。